The two companies have been partnered on Samsung Bioepis for the best part of a decade, successfully bringing six biosimilar copies of biologic drugs to regulatory approval, but Biogen now says it ...

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA ...

Eisai and Biogen have completed their rolling biologics license application in the US for a subcutaneous formulation of Alzheimer's disease therapy Leqembi previously delayed by the FDA on ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Needham sees no near-term catalysts for Biogen The brokerage said it sees Leqembi’s sales projection “likely to continue to be a slow grind, rather than see an inflection point” and said it ...

Please note that your conversations will be recorded. SearchBot: I am trained with Search Engine Land content. Ask me anything! Google Ads is experiencing technical issues. Users are reporting ...

After hours: 22 November at 7:57 pm GMT-5 ...

Plant immunity is the inherent or induced capacity of plants to withstand or ward off biological attack by pathogens. Molecules released from pathogens are recognised by plant cell surface ...

If you’re an existing customer looking for assistance, select the specific product you need help with below, and choose the resource or tool that works best for you. If you're not an existing customer ...

Genus Phytophthora threat various plant species including fruit, vegetable, and flower crops. The authors report that some NLRs recognize conserved effector families of multiple Phytophthora ...